TreeFrog Therapeutics is a French biotechnology company specialized in cell therapy. In April 2022, it announced the opening of a lab in Kobe, Japan, with the aim of establishing strategic alliances with key academic and industrial players in the field of regenerative medicine.
Case Study | cell | Export | Food | France | medical technology
This document is concerned with double taxation arising between the EU and Japan. The purpose of this document is to increase the understanding of double taxation, allowing readers to raise their concerns more accurately regarding double-taxation with their respective accountants.
What business opportunities does the Japanese Fintech market offer to EU SMEs? Opportunities stemming from large Japanese market to provide B2B services and products would be the main focus as therein lies most opportunities for EU SMEs.
How do Japanese firms consistently survive and become some of the oldest firms in the world? This report argues that Japanese and Western firms that showcase longevity follow certain key characteristics...
Topics covered on the September-October issue:
October 2022 - EU-Japan NEWS - the Centre's newsletter is now available on digital and PDF formats.
What are the key domestic players and the latest trends in the dynamic Japanese beer market? What are the opportunities for innovative or traditional EU craft-style beer manufacturers?
This report provides with the appropriate tools to choose between an Agency or a Distribution Agreement when doing business with a Japanese partner. It also provides the specific terminology (kanji) to distinguish between Distributor and Agency.